Therapeutic Class
Neuraminidase Inhibitor (Antiviral)

Indication
Treatment and prophylaxis of influenza A and B infections in adults and adolescents, in accordance with WHO-recommended guidelines.

Dosage & Administration
75 mg twice daily for treatment or 75 mg once daily for prophylaxis, or as prescribed by a healthcare professional.

To be used strictly as per recommended influenza treatment or prophylaxis regimens.

Storage
Store below 30°C in a dry place, protected from light and moisture.

Disclaimer
Prescription medicine. To be used only under medical supervision and in line with WHO-recommended treatment guidelines.